Manz Valuation

Is M5Z undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of M5Z when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: M5Z (€5.82) is trading below our estimate of fair value (€8.86)

Significantly Below Fair Value: M5Z is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for M5Z?

Key metric: As M5Z is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for M5Z. This is calculated by dividing M5Z's market cap by their current revenue.
What is M5Z's PS Ratio?
PS Ratio0.3x
Sales€222.64m
Market Cap€61.30m

Price to Sales Ratio vs Peers

How does M5Z's PS Ratio compare to its peers?

The above table shows the PS ratio for M5Z vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1x
CTNK centrotherm international
0.4xn/a€65.4m
TPE PVA TePla
0.9x4.9%€239.2m
S92 SMA Solar Technology
0.2x-1.0%€418.1m
SMHN SÜSS MicroTec
2.4x10.7%€919.5m
M5Z Manz
0.3x7.5%€59.5m

Price-To-Sales vs Peers: M5Z is good value based on its Price-To-Sales Ratio (0.3x) compared to the peer average (1x).


Price to Sales Ratio vs Industry

How does M5Z's PS Ratio compare vs other companies in the DE Semiconductor Industry?

2 CompaniesPrice / SalesEstimated GrowthMarket Cap
S92 SMA Solar Technology
0.2x-1.0%US$439.77m
D0Q Sondrel (Holdings)
0.2xn/aUS$2.02m
No more companies available in this PS range
M5Z 0.3xIndustry Avg. 1.7xNo. of Companies2PS012345+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: M5Z is good value based on its Price-To-Sales Ratio (0.3x) compared to the European Semiconductor industry average (1.7x).


Price to Sales Ratio vs Fair Ratio

What is M5Z's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

M5Z PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.3x
Fair PS Ratio0.8x

Price-To-Sales vs Fair Ratio: M5Z is good value based on its Price-To-Sales Ratio (0.3x) compared to the estimated Fair Price-To-Sales Ratio (0.8x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst M5Z forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€5.82
€8.35
+43.5%
1.8%€8.50€8.20n/a2
Nov ’25€6.80
€8.35
+22.8%
1.8%€8.50€8.20n/a2
Oct ’25€6.22
€8.35
+34.2%
1.8%€8.50€8.20n/a2
Sep ’25€5.50
€9.40
+70.9%
15.9%€11.50€8.20n/a3
Aug ’25€5.34
€9.57
+79.2%
14.3%€11.50€8.50n/a3
Jul ’25€5.30
€9.57
+80.5%
14.3%€11.50€8.50n/a3
Jun ’25€7.60
€12.00
+57.9%
25.7%€16.00€8.50n/a3
May ’25€7.62
€13.37
+75.4%
14.3%€16.00€11.50n/a3
Apr ’25€10.04
€13.37
+33.1%
14.3%€16.00€11.50n/a3
Mar ’25€9.57
€16.53
+72.8%
24.1%€22.00€12.60n/a3
Feb ’25€10.28
€16.53
+60.8%
24.1%€22.00€12.60n/a3
Jan ’25€12.34
€16.53
+34.0%
24.1%€22.00€12.60n/a3
Dec ’24€10.84
€16.53
+52.5%
24.1%€22.00€12.60n/a3
Nov ’24€8.16
€19.97
+144.7%
22.8%€26.00€15.00€6.803
Oct ’24€13.88
€19.97
+43.9%
22.8%€26.00€15.00€6.223
Sep ’24€14.92
€19.97
+33.8%
22.8%€26.00€15.00€5.503
Aug ’24€17.42
€23.43
+34.5%
7.8%€26.00€22.00€5.343
Jul ’24€19.04
€23.43
+23.1%
7.8%€26.00€22.00€5.303
Jun ’24€20.55
€26.33
+28.1%
14.0%€31.00€22.00€7.603
May ’24€23.80
€26.33
+10.6%
14.0%€31.00€22.00€7.623
Apr ’24€24.05
€26.33
+9.5%
14.0%€31.00€22.00€10.043
Mar ’24€22.15
€35.33
+59.5%
19.4%€45.00€30.00€9.573
Feb ’24€24.30
€35.33
+45.4%
19.4%€45.00€30.00€10.283
Jan ’24€21.05
€35.33
+67.9%
19.4%€45.00€30.00€12.343
Dec ’23€23.90
€35.33
+47.8%
19.4%€45.00€30.00€10.843
Nov ’23€27.55
€38.00
+37.9%
18.4%€45.00€31.00€8.162

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.


Discover undervalued companies